Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial.
David M CharytanJie YuMeg J JardineChristopher P CannonRajiv AgarwalGeorge BakrisTom GreeneAdeera LevinCarol PollockNeil R PoweClare ArnottKenneth W Mahaffeynull nullPublished in: Clinical journal of the American Society of Nephrology : CJASN (2022)
Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE), NCT02065791.
Keyphrases
- clinical evaluation
- small cell lung cancer
- type diabetes
- epidermal growth factor receptor
- cardiovascular disease
- density functional theory
- study protocol
- phase iii
- tyrosine kinase
- molecular dynamics
- molecular dynamics simulations
- glycemic control
- phase ii
- clinical trial
- diffusion weighted imaging
- human health
- magnetic resonance
- magnetic resonance imaging
- risk assessment
- metabolic syndrome
- climate change
- computed tomography